Table 4.
Comparison of IL-1β levels among the three groups prior and post treatment (pg/ml)
| Group | Prior treatment | At 2 weeks of treatment | At 4 weeks of treatment | 2 weeks post treatment | Ftime | P |
|---|---|---|---|---|---|---|
| Control (n=30) | 61.63±7.71 | 56.61±6.90 | 52.16±6.02 | 51.01±5.47 | 16.710 | < 0.001 |
| rTMS (n=31) | 61.41±7.44 | 55.36±6.77 | 48.05±4.66* | 46.03±4.97* | 41.740 | < 0.001 |
| rTMS + acupuncture (n=31) | 61.00±7.99 | 49.84±6.96*,# | 34.73±4.93*,# | 31.90±4.97*,# | 142.200 | < 0.001 |
| Fgroup | 0.051 | 8.430 | 93.240 | 114.200 | ||
| P | 0.951 | < 0.001 | < 0.001 | < 0.001 |
*
P < 0.05, indicating comparison with control group;
#
P < 0.05, indicating comparison with rTMS group.
IL-1β: interleukin-1β; rTMS: repetitive transcranial magnetic stimulation.